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Abstract (en français) 
Introduction: Le peptide natriurétique type B (BNP) est un marqueur reflétant le stress 
myocardique. Dans la population pédiatrique, la signification des valeurs préopératoire de BNP, 
en particulier sur l'évolution postopératoire, n'est pas clairement établie. Le but de l'étude est 
de déterminer la valeur prédictive de la partie NT sérique du BNP (NT-proBNP) sur l'évolution 
post opératoire d'enfants porteur d'une cardiopathie congénitale et ayant eu une chirurgie 
cardiaque. 
Résultats: Nonante-sept enfants ont été inclus dans l'étude, avec un âge médian de 3.3 ans 
[0.7-5.2]. La valeur médiane du NT-proBNP préopératoire était de 
412 pg/ml [164-1309]. Le NT-proBNP préopératoire était supérieur au P95 des valeurs de 
référence pour l'âge chez 56 patients (58%). Le NT-proBNP préopératoire était 
significativement plus élevé chez les patients ayant eu plus de deux jours de ventilation 
mécanique dans la période postopératoire (1156 pg/ml [281-1951] vs. 267 pg/ml [136-790], 
p=0.003) et ayant été hospitalisés plus de 6 jours dans l'unité de soins intensifs pédiatrique (727 
pg/ml [203-1951] vs. 256 pg/ml [136-790], p=0.007). Par contre, le NT-proBNP préopératoire 
n'était pas significativement plus élevé chez les patients ayant eu un score d'inotrope élevé 
pendant leur hospitalisation aux soins intensifs, un temps de circulation extracorporelle 
prolongé ou ayant subi une chirurgie avec un risque chirurgical élevé. 
Conclusions: Un NT-proBNP sérique élevé en préopératoire reflète l'importance du stress 
myocardique induit par l'hémodynamique et la dysfonction myocardique, il est un marqueur 
qui permet d'améliorer l'identification des patients à risque d'avoir une évolution post 
opératoire compliquée. 
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Abstract 
Introduction: B-type natriuretic peptide (BNP) is a biomarker of myocardial stress. In 
children, the value of preoperative BNP on postoperative outcome is unclear. The 
aim of this study was to determine the predictive value of preoperative NT-proBNP 
on postoperative outcome in children after congenital heart surgery. 
Results: Ninety-seven patients were included in the study with a median age of 3.3 
years [0.7-5.2]. Preoperative median NT-proBNP was 412 pg/ml [164-1309]. NT-
proBNP was above the P95 reference value for age in 56 patients (58%). Preoperative 
NT-proBNP was significantly higher in patients who had mechanical ventilation 
duration of more than 2 days (1156 pg/ml [281-1951] vs. 267 pg/ml [136-790], p=0.003) 
and who stayed more than 6 days in the pediatric intensive care unit (727 pg/ml [203-
1951] vs. 256 pg/ml [136-790], p=0.007). However, preoperative NT-proBNP was not 
significantly higher in patients with an increased inotropic score, a prolonged 
cardiopulmonary bypass time or an increased surgical risk category. 
Conclusions: An elevated preoperative NT-proBNP reflects hemodynamic status 
and cardiac dysfunction, and, therefore, is a valuable adjunct in predicting a 
complicated postoperative course. 
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Introduction 
Low cardiac output syndrome (LCOS) is a frequent complication after heart surgery 
for congenital heart disease in children, and may result in a poor outcome, increased 
mechanical ventilation duration and use of inotropic support, as well as increased 
length of stay in the pediatric intensive care unit (PICU). The early detection of LCOS 
can be challenging. Its prediction and anticipation allow improvement of 
postoperative management strategies thereby preventing further hemodynamic 
compromise. Causes of LCOS are multifactorial and include pre and perioperative 
factors [1]. 
Means to reliably identify, in the preoperative period, those patients at risk of 
developing LCOS, is a subject of great interest because of its impact on patient 
morbidity. The use of a reliable, easy-to-use, cardiac biomarker, predictive of early 
postoperative complications would be a valuable addition to the patient's evaluation. 
Preoperative dosage of NT-proBNP has been shown to be a useful prognostic 
biomarker of death and major cardiovascular complications in adults after heart 
surgery [2-5]. In the pediatric population, only a few studies suggest the usefulness 
of this biomarker as a preoperative risk stratification tool for children undergoing 
heart surgery [6-11]. 
B-type natriuretic peptide (BNP) is a cardiac hormone, with natriuretic, diuretic and 
vasodilator properties, secreted by the cardiomyocyte in response to volume or 
pressure overload [12,13]. It is produced within the cardiac ventricles, as a 
biologically inactive prohormone, proBNP. It is then cleaved in the bloodstream into 
BNP, the active hormone, and NT-proBNP, the inactive N-terminal fragment. NT-
proBNP is a stable peptide at room temperature with a longer half-life than BNP, 
which makes it a readily measurable biomarker [14]. Measured NT-proBNP 
concentrations and reference values are method-dependent and are influenced by 
age and gender of patients. Nir and colleagues published, in 2009, reference values 
and upper limits of NT-proBNP in healthy infants and children using the 
b: p Clin Cnu <oi. Volume 20. 's;-uc 10. 20M - Paye 653S 
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electrochemiluminescence assay, Elecsys system 1010/2010, Roche Diagnostics [15]. 
These reference values have been used for our analysis. 
The aim of our study was to determine the predictive value of preoperative NT-
proBNP on postoperative outcome in children undergoing cardiac surgery for 
congenital heart disease. Due to the difficulty of assessing LCOS with objective 
parameters we opted to use mechanical ventilation duration (MVD), inotropic score 
(IS) and length of stay in PICU (LOS) as endpoint surrogates for LCOS. 
Materials and methods 
Our institutional research ethics committee approved the study and specifically 
waived the requirement for informed consent. 
Preoperative NT-proBNP was measured in a prospective cohort of successive 
patients, aged 0-16, undergoing cardiac surgery for congenital heart disease and 
admitted, after surgery, to the PICU for postoperative management. 
Measurements of NT-proBNP were performed with the Elecsys 2010 proBNP kit 
(Roche Diagnostics), which uses an electrochemiluminescence (ECLIA) 
immunoassay with an analytical range between 5-35000 pg/ml. Other preoperative 
data included demographics of patients, diagnosis of congenital heart disease and 
surgical risk categories. Intraoperative data included cardiopulmonary bypass (CPB) 
time and aortic cross-clamping time. Postoperative data included mechanical 
ventilation duration, inotropic score at 24 hours postoperatively and PRISM score. 
Data were prospectively collected using our point-of-care Clinical Information 
System (Metavision®, iMDSoft) and retrospectively analyzed. Age-dependent 
reference values (mean and P95) of NT-proBNP were used [15], 
Preoperative NT-proBNP was correlated to postoperative outcome measures used as 
surrogate endpoints for LCOS: mechanical ventilation duration (MVD), inotropic 
score (IS) and length of stay (LOS). 
The maximal amount of inotropic support needed in the first 24 hours 
postoperatively was calculated using the modified inotropic score (IS) which is 
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defined by the following formula: dopamine dose (mcg/kg/min) + dobutamine dose 
(mcg/kg/min) + (milrinone dose (mcg/kg/min) x 10) + (adrenaline dose (mcg/kg/min) 
x 100) + (noradrenaline dose (mcg/kg/min) x 100) [16,17]. According to other 
publications, we determined an increased inotropic score above 20 [17]. 
In order to define group categories of prolonged MVD and LOS for the analysis, we 
decided, according to our experience, that a prolonged MVD was more than 2 days 
and a prolonged LOS more than 6 days. 
The PRISM-II (Paediatric Risk of Mortality) score was developed from the 
Physiologic Stability Index (PSI) to reduce the number of physiologic variables 
required for paediatric ICU mortality risk assessment and to obtain an objective 
weighing of the remaining variables. According to the literature, a score above 10 is 
predictive of increased mortality in PICU patients [18]. 
RACHS-1 (Risk Adjusted classification for Congenital Heart Surgery) was created in 
order to compare in-hospital mortality for groups of children younger than 18 years 
undergoing surgery for congenital heart disease [19]. RACHS groups surgical 
procedures for congenital heart disease into six categories of increasing predictive 
operative risk. We defined categories of surgical risk and CPB time as RACHS > 3. 
We determined prolonged CPB time as more thanlOO minutes in order to identify 
confounding factors for LCOS. 
Statistical analysis was done using Stata 13.1 version. Data is presented as median 
with interquartile range. Chi-square test was used to assess the association between 
preoperative NT-proBNP and MVD, IS and LOS. Wilcoxon's rank sum test was used 
to test associations for skewed variables. The significance level was set at 5 percent. 
Results 
A total of 97 patients, 37 females and 60 males, were included in the study. Age 
ranged from 1 day to 16 years (median 3.3 years [0.7-5.2]). 
RACHS categories and major diagnostic groups are defined in Table 1. Major 
diagnostic groups included conotruncal anomalies (tetralogy of Fallot, double outlet 
Exp CHn Ceruiol, Volume 'Â>. issue 10, 2014 - PageSôQI 
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right ventricle, and truncus arteriosus), atrial septal defects, ventricular septal 
defects, atrioventricular septal defects, right and left outflow tract obstructive lesions 
(subvalvar, valvar and supravalvar aortic and pulmonary stenosis), aortic 
coarctation, partial and total anomalous pulmonary venous return, coronary 
anomalies and single ventricle defects. 
Insert Table 1 
Preoperative NT-proBNP ranged from 12 to > 35000 pg/ml (median 412 pg/ml [164-
1309]). Cardiopulmonary bypass time ranged from 25 to 319 minutes (median 95 
minutes [70-135]). Aortic cross-clamping time ranged from 0 to 222 minutes (mean 53 
minutes [34-72]). PRISM ranged from 0 to 23 (median 4 [2-7]). LOS ranged from 2 to 
56 days (median 6 days [4.1-9.9]). MVD ranged from 0.5 to 17.5 days (median 1.8 
days [0.9-5.8]). Inotropic score ranged from 0 to 92 (median 14.5 [5-36]). There was no 
mortality in our study group. The demographic and outcome data are summarized 
in Table 2. 
Insert Table 2 
Preoperative NT-proBNP was above the median reference value for age in 91 
children (94%) of the population studied, and above the P95 reference value for age 
in 56 children (58%). 
Children with a preoperative NT-proBNP > P95 were significantly younger than 
those with a preoperative NT-proBNP < P95 (1.7 years [0.5-4.8] vs. 4.3 years [1.9-5.2], 
p=0.02). Children younger than one year were more frequently found to have a 
preoperative NT-proBNP above P95 compared to the children older than 1 year 
(24/32 patients (75%) vs. 32/65 patients (49%), p=0.016). 
Insert Table 3 
Table 3 summarizes our outcome results. Preoperative NT-proBNP values were 
significantly higher in patients ventilated more than 2 days compared to those 
patients ventilated less than 2 days (1156 pg/ml [281-1951] vs. 267 pg/ml [136-790], 
p=0.003). Preoperative NT-proBNP was also significantly higher in children with a 
LOS greater than 6 days compared to those with a LOS shorter than 6 days (727 
i-yn Clin Cans;"!. Va'uirie 20. Issue 10. 20M - Pace 6602 
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pg/ml [203-1951] vs. 256 pg/ml [136-790], p=0.007). Similarly, preoperative NT-
proBNP was significantly higher in patients with a PRISM score above 10 compared 
to patients with a PRISM score under 10 (1856 pg/ml [952-6267] vs. 350 pg/ml [161-
1200], p=0.01). Preoperative NT-proBNP values did not statistically differ between 
RACHS groups (RACHS < 3 and > 3), cardiopulmonary bypass time (CPB < 100 min 
and CPB > 100 min) and inotropic score (IS < 20 and IS > 20) groups. 
Discussion 
Our study demonstrates that patients requiring more prolonged mechanical 
ventilation support and having a longer length of stay had a significantly higher 
preoperative NT-proBNP than those with shorter MVD and LOS. Furthermore, 
patients with a high PRISM score upon admission in PICU had a significantly higher 
preoperative NT-proBNP than those with a low PRISM score. These outcome 
measures reflect disease severity and a complicated postoperative course, and were 
used as surrogate endpoints of LCOS. However, our study failed to show any 
significant correlation between preoperative NT-proBNP and the maximal inotropic 
score over the first 24 hours in PICU. This suggests the influence of other factors than 
LCOS alone on the in IS, such as, the duration of CPB, the inflammatory cascade 
triggered by CPB leading to varying degrees of vasoplegia, the need for sedation, 
etc... Interestingly, patients with a higher RACHS category, who underwent more 
complex surgical repairs, as well as patients that had a longer CPB duration, did not 
show any significant differences in preoperative NT-proBNP values. This suggests 
that preoperative NT-proBNP is somehow an independent risk factor for a 
complicated postoperative course and doesn't influence intraoperative factors as the 
type of surgical repair or CPB duration. Preoperative NT-proBNP reflects the 
severity of heart failure symptoms and cardiac function impairment and is, therefore, 
indicative of the preoperative hemodynamic status of the patient, irrespective of the 
congenital heart defect. This, however, appears to be unrelated to the difficulty of the 
surgery performed on the patient. 
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The interpretation of preoperative NT-proBNP measurements must take into account 
the method of measure, the gender of the patient, but, above all, the age of the 
patient, in particular infants who show higher reference values than the older child. 
Interestingly, we found that children younger than one year had higher preoperative 
NT-proBNP, which not only reflects the usual tendency to have a higher NT-proBNP 
in that age group, but also suggests that younger children with heart defects may 
present with more severely impaired cardiac function. 
In the pediatric literature, there is conflicting evidence concerning the benefit of 
preoperative NT-proBNP and its predictive value on postoperative outcome. For 
example, Gessler and colleagues examined the outcome of 40 patients, aged 3 months 
to 7 years with various congenital heart defects undergoing cardiac surgery and 
found that preoperative NT-proBNP correlated significantly with the inotropic score 
in the first 24 hours, the duration of inotropes as well as the duration of mechanical 
ventilation. However, no correlation was found between preoperative NT-proBNP 
and RACHS categories [6]. By looking at results in 38 patients younger than three 
years with left ventricular volume overload cardiac lesions only, Walsh and 
colleagues showed, similarly, a significant correlation between preoperative NT-
proBNP and duration of mechanical ventilation, LOS in the PICU, CPB duration and 
the Therapeutic Intervention Scoring System (TISS) score over the first 72 hours [9] 
Likewise, Nahum and colleagues found a significant correlation between increased 
preoperative BNP and need for increased postoperative inotropic support, longer 
MVD and LOS in infants younger than 1 year [11]. In contrast, Hsu and colleagues 
found no association between preoperative BNP levels and ventilator-free days or 
length of PICU stay in 36 neonates (<30 days) undergoing cardiac surgery [8]. These 
different studies demonstrate that the correlation of preoperative BNP with operative 
and postoperative outcomes can be confusing in the congenital cardiac population. 
Pediatric congenital heart surgery is particular in that it deals with a great number of 
heterogeneous heart defects requiring specific surgical repairs, which differ quite 
significantly depending on the heart defect. The age, hemodynamic and clinical 
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status at the time of surgery can also be quite variable. These above-mentioned 
factors inevitably impact on BNP secretion. Due to the relative infrequence of 
patients with similar heart defects and demographic variables, it is, in that respect, 
quite a challenge to study homogeneous groups. This fact certainly explains, in part, 
the conflicting results found in the literature concerning the predictive value of 
preoperative NT-proBNP. Our cohort of patients, even though heterogeneous in 
terms of age and congenital heart defect is one of the largest found in the literature 
on the subject and constitutes thereby one of the strength of this study. 
In contrast to what is found in the pediatric literature, numerous studies done with 
adults undergoing cardiac surgery have clearly shown the prognostic value of pre-
operative NT-proBNP as it correlates significantly with in-hospital ventricular 
dysfunction and need for inotropic or mechanical support, length of stay and 5 year 
mortality [2-4]. They have clearly demonstrated the benefit of adding preoperative 
NT-proBNP to the already existing cardiac surgical risk stratification models. 
Preoperative NT-proBNP may indeed help discriminate the marginal patients, with 
few clinical symptoms, that can benefit from a better preoperative medical and 
surgical preparation. 
Approximately 25% of children develop LCOS after cardiac surgery for congenital 
heart disease [1,20]. It occurs typically within the first 12 hours after 
cardiopulmonary bypass and often has a multifactorial origin; some factors are 
intraoperative, like CPB duration and aortic cross-clamping duration, some are 
postoperative, like reperfusion injuries, increase in systemic or pulmonary vascular 
resistances or a CPB induced inflammatory cascade. LCOS is fundamentally a clinical 
diagnosis, yet a number of direct methods of assessment, like lactate levels and 
mixed venous oxygen saturation, are available to aid in the diagnosis. Direct and 
continuous measurement of cardiac output is rarely performed in pediatric patients 
due to the invasiveness of these techniques. LCOS is a predictable event and so, 
anticipation is the cornerstone to diagnosis and management. The development of a 
predictive LCOS score, including objective variables, like a reliable biomarker such as 
fcji|j Clin Cr rtficf, i/uiumc 2û. issus in, 20H Page 6505 
The predictive value of prcjoperaltva b-iype natriuretic popude In children unuergoln... 
10 
NT-proBNP, could certainly assist in identifying those patients at risk of presenting a 
complicated postoperative course rather than using surrogates of LCOS, like IS, 
MVD and LOS, which are, when taken individually, partial and incomplete 
indicators. For these patients management strategies of the perioperative and 
postoperative period could be improved by adopting more aggressive measures 
aimed at preventing low cardiac output syndrome. 
Certain limitations to this study should be noted, including the heterogeneous nature 
of the population studied, notably with regards to age of patients and diversity of 
congenital heart defects, which both independently influence NT-proBNP 
measurements, complicating the interpretation of results. It would be preferable to 
study age-specific and lesion-specific subset of patients in order to minimize the 
biases. The retrospective nature of this group of surgical patients may introduce as 
well some bias into the analysis of the data. To overcome these limitations, further 
studies are needed, yet this implies working in a prospective multi-centric fashion in 
order to increase the number of patients recruited. 
Conclusions 
Preoperative NT-proBNP appears to be a valuable marker that can help identifying, 
before surgery, certain patients at risk of developing postoperative complications. A 
high preoperative NT-proBNP in children with congenital heart defect is indicative, 
above all, of significant myocardial stress. This population could benefit from more 
aggressive strategy in the postoperative period, aimed at preventing low cardiac 
output syndrome. Further studies are needed to confirm our findings and strengthen 
the value of preoperative NT-proBNP as a reliable and predictive marker of 
postoperative outcome in children undergoing cardiac surgery. 
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Table 1. RACHS-1 categories and major diagnostic groups 
RACHS-1 
1 
2 
3 
4 
6 
Diagnosis 
ASD 
Aortic coarctation (>30 days) 
VSD 
Tetralogy of Fallot 
Pulmonary stenosis (valvar/supravalvar) 
Aortic stenosis (valvar/subvalvar) 
Partial AVSD 
TAPVR 
Common atrium with PAPVR 
Tetralogy of Fallot 
DORV 
Aortic stenosis/insufficiency (valvar, supravalvar) 
Pulmonary stenosis (valvar/supravalvar) 
Complete AVSD (balanced and unbalanced) 
Cor triatrium 
Tricuspid & mitral insufficiency 
Coronary anomalies 
Tricuspid atresia 
PA-IVS and hypoplastic RV 
Truncus arteriosus 
Double-inlet single ventricle 
Number of 
patients (n=97) 
2 
1 
23 
21 
1 
3 
1 
1 
1 
10 
5 
7 
2 
7 
1 
3 
2 
3 
1 
1 
1 
ASD, Atrial septal defect ; AVSD, Atrioventricular septal defect ; DORV, Double 
outlet right ventricle ; PA-IVS, Pulmonary atresia with intact ventricular septum ; 
PAPVR, partial anomalous pulmonary venous return ; RACHS-1, Risk adjusted 
classification for congenital heart surgery; TAPVR, total anomalous pulmonary 
venous return. 
:l . U î K l t î l ' 
Table 2. Demographic and outcome data 
N=97 
Weight (kg) 
Height (cm) 
Age (years) 
NT-proBNP (pg/ml) 
CPB time (min) 
Aortic clamping time (min) 
MVD (days) 
LOS PICU (days) 
Inotropic score at 24 hours 
PRISM score 
Median [IQR] 
11.3 [6.5-16.0] 
91[68-108] 
3.3 [0.7-5.2] 
412 [164-1309] 
95 [70-135] 
53 [34-72] 
1.8 [0.9-5.8] 
6.0 [4.1-9.9] 
14.5 [5-36] 
4 [2-7] 
15 
Data are presented as median [IQR]. CPB, Cardiopulmonary bypass; LOS, Length of 
stay; MVD, Mechanical ventilation duration; PICU, Pediatric intensive care unit; 
PRISM, Pediatric risk of mortality score. 
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Table 3. NTpro-BNP values and outcomes 
16 
MVD < 2 days vs. > 2 days 
LOS PICU < 6 days vs. > 6 days 
Inotropic score < 20 vs. > 20 
PRISM score < 10 vs. > 10 
CPB time < 100 min. vs. > 100 min. 
RACHS-1 <3vs .>3 
NT-proBNP (pg/ml) 
267 [136-790] vs. 1156 [281-1951] 
256 [136-790] vs. 727 [203-1951] 
350 [161-1171] vs. 555 [198-1908] 
350 [161-1200] vs. 1856 [952-6267] 
425[164-1229] vs. 368 [147-1848] 
364 [144-1171] vs. 467 [199-1951] 
P 
0.003 
0.007 
0.27 
0.01 
0.85 
0.22 
Data are presented as median [IQR]. CPB, Cardiopulmonary bypass; LOS, Length of 
stay; MVD, Mechanical ventilation duration; PICU, Pediatric intensive care unit; 
PRISM, Pediatric risk of mortality score; RACHS-1, Risk adjusted classification for 
congenital heart surgery. 
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